Medion Grifols Diagnostics AG

Medion Grifols Diagnostics continues a tradition in immunohematology that began 60 years ago with Merz and Dade. After refounding in 2006 as Medion Diagnostics AG with legal domicile in Switzerland, the company name was changed in 2010 to Medion Grifols Diagnostics upon acquisition through Grifols.

Medion Grifols Diagnostics manufactures and distributes Reagent Red Blood Cells, Antisera, Controls for DG Gel and conventional  tube technique and MDmulticard Reagents. Over the years, our products have been benchmarking the field of immunohematology. In the last two decades, the portfolio was enhanced by novel proprietary technology (MDmulticard) and dedicated product developments for manual and automated Grifols DG Gel technique.

Bonnstrasse, 9
CH-3186 Düdingen
SWITZERLAND

Contact information
Tel: +41 26 492 85 11
Fax: +41 26 492 86 57
E-mail: info@medion-diagnostics.ch

Contact Us

Thank you for contacting us. We will reply as soon as possible.

ACCEPT

Thank you for your interest in learning more about our company. We care about your questions and concerns and we will reply you as soon as possible. Please complete all required fields as this will enable us to process your request more efficiently. The company identified in this section is the data controller and will process your personal data based on your consent as expressed in this form. You can exercise your rights of access, rectification, erasure and other data protection rights and obtain additional information on how your personal data is processed in the Privacy Policy

Text to Identify
DATA PROTECTION INFORMATION
Data controller The Grifols' group company to which you have submitted the request
Purpose To attend your requests of information and/or suggestions
Legal basis Consent
Recipients Grifols' group companies
Rights To access, rectify or erase, as well as any other rights as specified in the additional information layer
Additional information You may access the additional and detailed information on data protection here.